Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 26, 2018 08:50 ET | Source: Arch Biopartners

Arch Biopartners Announces Non Brokered Private Placement Financing

TORONTO, Jan. 26, 2018 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (Arch or the Company) (TSX-V:ARCH) (OTCBB:ACHFF) a portfolio based biotechnology company, intends to complete a non-brokered private...
December 06, 2017 10:08 ET | Source: Arch Biopartners

Arch Biopartners Announces Completion of GMP Manufacturing of AB569 and Start Date of Phase I Trial

TORONTO, Dec. 06, 2017 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (Arch or the Company) (TSX Venture:ARCH) (OTCBB:ACHFF) today announced that the good manufacturing practice (GMP) production...
November 01, 2017 10:09 ET | Source: Arch Biopartners

Arch Biopartners Engages Nucro Technics to Begin Toxicology Studies for Metablok

TORONTO, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Arch Biopartners, Inc., (Arch or the Company) (TSX Venture:ARCH)(OTCBB:ACHFF) a portfolio-based biotechnology company, today announced it has engaged Nucro...
October 24, 2017 08:00 ET | Source: Arch Biopartners Inc.

Arch Biopartners Closes Convertible Note Financing

TORONTO, ONTARIO--(Marketwired - Oct. 24, 2017) - Arch Biopartners Inc., ("Arch" or the "Company") (TSX VENTURE:ARCH)(OTCBB:ACHFF), announced it has closed a non-brokered, unsecured...
October 10, 2017 06:30 ET | Source: Arch Biopartners Inc.

Arch Biopartners Initiates Manufacturing Process for Metablok

TORONTO, ONTARIO--(Marketwired - Oct. 10, 2017) - Arch Biopartners, Inc., (Arch or the Company) (TSX VENTURE:ARCH)(OTCBB:ACHFF) a portfolio-based biotechnology company, today announced it...
September 28, 2017 08:30 ET | Source: Arch Biopartners Inc.

Arch Biopartners' GMP Manufacturing of AB569 Progresses to Final Production Stage

TORONTO, ONTARIO--(Marketwired - Sept. 28, 2017) - Arch Biopartners, Inc., (Arch or the Company) (TSX VENTURE:ARCH)(OTCBB:ACHFF) today announced that the good manufacturing practice (GMP)...
September 12, 2017 08:59 ET | Source: Arch Biopartners Inc.

Arch Biopartners Increases Non-Brokered Private Placement Financing

TORONTO, ONTARIO--(Marketwired - Sept. 12, 2017) - Arch Biopartners Inc., (Arch or the Company) (TSX VENTURE:ARCH)(OTCBB:ACHFF), announced today it has increased the size of the...
August 10, 2017 10:07 ET | Source: Arch Biopartners Inc.

Arch Biopartners Closes Non-Brokered Private Placement Financing

TORONTO, ONTARIO--(Marketwired - Aug. 10, 2017) - Arch Biopartners Inc., (Arch or the Company) (TSX VENTURE:ARCH)(OTCBB:ACHFF), announced today it has closed the non-brokered private placement...
July 27, 2017 12:43 ET | Source: Arch Biopartners Inc.

Arch Biopartners Provides Update on GMP Manufacturing of AB569

TORONTO, ONTARIO--(Marketwired - July 27, 2017) - Arch Biopartners, Inc., (Arch or the Company) (TSX VENTURE:ARCH)(OTCBB:ACHFF) today provided an update on the progress of the good...
July 24, 2017 16:00 ET | Source: Arch Biopartners Inc.

Arch Biopartners Retains Market Maker and Arranges Non Brokered Private Placement Financing

TORONTO, ONTARIO--(Marketwired - July 24, 2017) - Arch Biopartners Inc., (Arch or the Company) (TSX VENTURE:ARCH)(OTCBB:ACHFF) announced today it has retained Mackie Research Capital...